CIM

Chimera Investment Corp

Add to Watchlist

Advanced Chart

14.040

+0.05(0.357%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

14.105

Open

14.050

VWAP

14.03

Vol

488.84K

Mkt Cap

1.14B

Low

13.880

Amount

6.86M

EV/EBITDA(TTM)

92.61

Total Shares

80.47M

12.62B

EV/OCF(TTM)

104.54

P/S(TTM)

1.48

Chimera Investment Corporation is a real estate investment trust (REIT). The Company is engaged in the business of investing in a diversified portfolio of mortgage assets for itself and for unrelated third parties through its investment management and advisory services. The assets it may invest in and manage for others include residential mortgage loans, non-agency residential mortgage-backed securities (RMBS), agency RMBS, business purpose loans (BPLs) (including residential transition loans (RTLs)) and investor loans, mortgage servicing rights (MSRs) and other real estate-related assets such as Agency CMBS, junior liens and home equity lines of credit (HELOCs), equity appreciation rights, and reverse mortgages. The MBS and other real estate-related securities it purchases includes investment-grade, non-investment grade, and non-rated securities. The Company is focused on investing in commercial mortgage loans consisting of first or second lien loans secured by multifamily properties.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

86.97M

+25.64%

0.467

+13.87%

84.98M

+29.1%

0.442

+19.45%

84.51M

+27.18%

0.437

+21.41%

Estimates Revision

The market is revising Downward the revenue expectations for Chimera Investment Corporation (CIM) for FY2025, with the revenue forecasts being adjusted by -1.45% over the past three months. During the same period, the stock price has changed by 2.63%.

Revenue Estimates for FY2025

Revise Downward

-1.45%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-11.32%

In Past 3 Month

Stock Price

Go Up

+2.63%

In Past 3 Month

3 Analyst Rating

Wall Street analysts forecast CIM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CIM is 15.50 USD with a low forecast of 15.00 USD and a high forecast of 16.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

2 Hold

0 Sell

Moderate Buy

Current: 14.040

Low

15.00

Averages

15.50

High

16.00

Current: 14.040

Low

15.00

Averages

15.50

High

16.00

Keefe Bruyette

Market Perform

downgrade

$15

2025-07-10

Reason

Keefe Bruyette

Price Target

$15

2025-07-10

downgrade

Market Perform

Reason

Keefe Bruyette lowered the firm's price target on Chimera to $15 from $16.50 and keeps a Market Perform rating on the shares.

UBS

Buy

maintain

$15 -> $16

2025-07-10

Reason

UBS

Price Target

$15 -> $16

2025-07-10

maintain

Buy

Reason

UBS raised the firm's price target on Chimera to $16 from $15 and keeps a Buy rating on the shares.

UBS

Neutral -> Buy

upgrade

$15

2025-05-14

Reason

UBS

Price Target

$15

2025-05-14

upgrade

Neutral -> Buy

Reason

UBS upgraded Chimera to Buy from Neutral with a price target of $15, up from $11.50. The firm cites the company's better than expected book value performance in Q1 and April, plus higher near-term earnings expectations for the upgrade. The biggest source of the upside comes from Chimera's ability to optimize its liabilities to free up additional capital for reinvestment, the analyst tells investors in a research note. UBS points out the shares are trading at 61% of book value.

JMP Securities

Aaron Hecht

Hold

Reiterates

n/a

2025-01-23

Reason

JMP Securities

Aaron Hecht

Price Target

n/a

2025-01-23

Reiterates

Hold

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Chimera Investment Corp (CIM.N) is 7.66, compared to its 5-year average forward P/E of 8.70. For a more detailed relative valuation and DCF analysis to assess Chimera Investment Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

8.70

Current PE

7.66

Overvalued PE

10.32

Undervalued PE

7.07

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

4.53

Current PS

3.29

Overvalued PS

5.72

Undervalued PS

3.33